# US 2013/0261111 A1 · Tetrahydropyrrolothiazine compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0261111 A1
- Document ID: US20130261111A1
- Status: Published application
- Kind: A1
- Application number: 13/851,116
- Filed: 2013-03-27
- Published: 2013-10-03
- Earliest claimed: 2012-04-03
- Assignees: Eli Lilly and Company
- Applicants: Eli Lilly and Company
- Inventors: James Peter BECK; Steven James GREEN; Jose Eduardo LOPEZ; Brian Michael MATHES; Dustin James MERGOTT; Warren Jaye PORTER; Zoran RANKOVIC; Yuan SHI; Brian Morgan WATSON; Leonard Larry WINNEROSKI, JR
- Web page: https://patentgrep.com/patent/US20130261111A1

## CPC

- C07D 513/04: Ortho-condensed systems
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides compounds of Formula I: wherein A is selected from the group consisting of; R1 is H or F; R2 is H, —CH2OH, C1-C3 alkyl, R3 is H, F, or CN; R4 is H, F; or CN; and R5 is H, —CH3, or —OCH3; or a pharmaceutically acceptable salt thereof.

## Claims

### Claim at position 1

1-10. (canceled)

### Claim 11

A compound which is (4aR,7aR)-6-(5-fluoropyrimidin-2-yl)-7a-isothiazol-5-yl-4,4-a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-2-amine:
or a pharmaceutically acceptable salt thereof.

### Claim 12 (depends on 11)

A compound according to claim 11 which is (4aR,7aR)-6-(5-fluoropyrimidin-2-yl)-7a-isothiazol-5-yl-4,4-a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-2-amine:

### Claim at position 4

13-18. (canceled)
